Skip to main content
. 2020 Dec 30;14:4551–4559. doi: 10.2147/OPTH.S285953

Figure 2.

Figure 2

The TearCare System is effective in managing signs and symptoms of MGD and DED. Improvements were seen in (A) TBUT, (B) Meibomian Gland Score, (C) Corneal and Conjunctival Staining, and (D) OSDI scores. * and ** indicate p-values < 0.001.